Two Mount Sinai Researchers Elected to National Academy of Medicine
Alison M. Goate, D.Phil, Professor of Neuroscience, Neurology and Genetic and Genomic Sciences at the Icahn School of Medicine at Mount Sinai, and Lynne D. Richardson, MD, FACEP, Professor of Emergency Medicine and Population Health Science and Policy, have been elected as two of 79 new members to the prestigious National Academy of Medicine (NAM), formerly known as The Institute of Medicine (IOM).
“Election to the National Academy of Medicine is considered one of the highest honors in medicine,” says Dennis S. Charney, MD, the Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai. “The election of Drs. Goate and Richardson is a notable achievement and well-deserved recognition of each of their leadership efforts and important contributions to their particular fields of study.”
Dr. Goate is an internationally renowned neuropsychiatric researcher and the founding Director of The Ronald M. Loeb Center for Alzheimer’s Disease at Mount Sinai. As a molecular geneticist, Dr. Goate has established an international reputation for her research to elucidate the genetic, molecular, and cellular basis of Alzheimer’s disease (AD) and related neurodegenerative disorders. Dr. Goate has identified key gene mutations linked to the heritable risk for Alzheimer’s disease, including her finding that a rare mutation of the PLD3 gene doubles the risk of developing late-onset AD. Prior to joining Mount Sinai, she led a team of researchers at Washington University in St. Louis that performed the largest ever genome-wide association study of protein markers found in cerebrospinal fluid, resulting in the discovery of three genetic variants associated with an increased risk of developing AD.
Dr. Richardson is Professor and Vice Chair of Emergency Medicine and Professor of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai. She is a practicing emergency physician and a nationally recognized expert in health services research. Dr. Richardson’s areas of interest are access and barriers to care, improving effective utilization of health care resources, and health care disparities. She is principal investigator (PI) for an NIH-funded study which is seeking to improve effective methods for communicating with communities about emergency research. She is also PI of a trial focused on prevention and early treatment of acute lung injury and of the New York City Sickle Cell Implementation Science Consortium. With a strong track record of mentoring young investigators to successful research careers, Dr. Richardson directs a research career development program in emergency medicine and an emergency care research fellowship program. She also received a Health Care Innovation Award from the Centers for Medicare and Medicaid Services to implement a new model of emergency care for older adults.
New members are elected by current, active members through a selective process that recognizes people who have made major contributions to the advancement of the medical sciences, health care, and public health. Established in 1970 by the National Academy of Sciences, NAM is a national resource that provides independent, objective analysis and advice on health issues.
The new NAM members bring Mount Sinai’s total membership in the prestigious group to 21. The distinguished Mount Sinai faculty members who Drs. Goate and Richardson join in earning this honor are: • Joseph D. Buxbaum, PhD • Dennis S. Charney, MD • Kenneth L. Davis, MD • Robert J. Desnick, MD, PhD • Kurt W. Deuschle, MD •Angela Diaz, MD, MPH • Valentin Fuster, MD, PhD • Bruce Gelb, MD • E. Cuyler Hammond • Kurt Hirschhorn, MD • Philip J. Landrigan, MD, MSc • Diane E. Meier, MD • Eric J. Nestler, MD, PhD • Maria Iandolo New, MD • Peter Palese, PhD • Hugh A. Sampson, MD • Irving J. Selikoff, MD • Pamela Sklar, MD, PhD • Barbara G. Vickrey, MD, MPH.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report's Best Hospitals, receiving high "Honor Roll" status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children's Hospital among the country’s best in several pediatric specialties.